Crossmark

Pain and dyspnea control during awake fiberoptic bronchoscopy in critically ill patients: safety and efficacy of remifentanil target-controlled infusion

Crossref DOI link: https://doi.org/10.1186/s13613-021-00832-6

Published Online: 2021-03-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Caron, Margot

Parrot, Antoine

Elabbadi, Alexandre

Dupeyrat, Sophie

Turpin, Matthieu

Baury, Thomas

Rozencwajg, Sacha

Blayau, Clarisse

Fulgencio, Jean-Pierre

Gibelin, Aude

Blanchard, Pierre-Yves

Rodriguez, Séverine

Daigné, Daisy

Allain, Marie-Cécile

Fartoukh, Muriel

Pham, Tài http://orcid.org/0000-0002-4373-0711
License Information

Text and Data Mining valid from 2021-03-16

Version of Record valid from 2021-03-16
More Information

Article History

Received: 25 September 2020

Accepted: 2 March 2021

First Online: 16 March 2021

Declarations

:

: This study was conducted in accordance with the amended Declaration of Helsinki and was approved by the local ethics committee (Comité de protection des personnes, Ile de France V, Project number 14983, 2014). All patients consented to participate.

: Not applicable.

: The authors declare that they have no competing interests to declare.

Document is current

Any future updates will be listed below